CN101502654B - 高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 - Google Patents
高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 Download PDFInfo
- Publication number
- CN101502654B CN101502654B CN2008102432305A CN200810243230A CN101502654B CN 101502654 B CN101502654 B CN 101502654B CN 2008102432305 A CN2008102432305 A CN 2008102432305A CN 200810243230 A CN200810243230 A CN 200810243230A CN 101502654 B CN101502654 B CN 101502654B
- Authority
- CN
- China
- Prior art keywords
- elsinochrome
- plain
- silica dioxide
- nsc
- nano particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229930184149 elsinochrome Natural products 0.000 title claims abstract description 68
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000010253 intravenous injection Methods 0.000 title claims description 9
- 239000008187 granular material Substances 0.000 title description 3
- 229910052814 silicon oxide Inorganic materials 0.000 title description 3
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 claims abstract description 58
- 229910000077 silane Inorganic materials 0.000 claims abstract description 35
- -1 silane terpenoid Chemical class 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 8
- SVDUCZIGPIYIHQ-HZPDHXFCSA-N (1r,2r)-1,2-diacetyl-4,11-dihydroxy-3,7,8,12-tetramethoxy-1,2-dihydrobenzo[ghi]perylene-5,10-dione Chemical compound COC1=CC(=O)C=2C3=C1C(C(OC)=CC1=O)=C4C1=C(O)C(OC)=C([C@@H]([C@H]1C(C)=O)C(C)=O)C4=C3C1=C(OC)C=2O SVDUCZIGPIYIHQ-HZPDHXFCSA-N 0.000 claims description 67
- 239000003814 drug Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 9
- 239000005543 nano-size silicon particle Substances 0.000 claims description 9
- 239000000376 reactant Substances 0.000 claims description 8
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 238000001990 intravenous administration Methods 0.000 claims description 4
- INJVFBCDVXYHGQ-UHFFFAOYSA-N n'-(3-triethoxysilylpropyl)ethane-1,2-diamine Chemical compound CCO[Si](OCC)(OCC)CCCNCCN INJVFBCDVXYHGQ-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 3
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 claims description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 abstract description 21
- 239000000377 silicon dioxide Substances 0.000 abstract description 7
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 6
- 238000004321 preservation Methods 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 210000003462 vein Anatomy 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 238000001782 photodegradation Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 22
- 239000003504 photosensitizing agent Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 238000002428 photodynamic therapy Methods 0.000 description 10
- 238000011160 research Methods 0.000 description 7
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 241001597008 Nomeidae Species 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- DYLMNCRRGPXGBV-UHFFFAOYSA-N elsinochrome A Natural products COc1c(O)c2C(=O)C=C3C(C(C(=O)C)C4=CC(=O)c5c(O)c(OC)c(OC)c6c(c1OC)c2c3c4c56)C(=O)C DYLMNCRRGPXGBV-UHFFFAOYSA-N 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 150000004756 silanes Chemical class 0.000 description 3
- 238000006277 sulfonation reaction Methods 0.000 description 3
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 2
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- IYYMDGDZPDXTGT-UHFFFAOYSA-N perylene-1,2-dione Chemical class C1=CC(C2=C3C(=CC(C2=O)=O)C=CC=C32)=C3C2=CC=CC3=C1 IYYMDGDZPDXTGT-UHFFFAOYSA-N 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000161991 Fargesia Species 0.000 description 1
- 241000143667 Hypocrella Species 0.000 description 1
- KGHNSNSWRMJVND-UHFFFAOYSA-N Hypocrellin Natural products COC1=CC(=O)C2=C3C4C(C(C(=O)C)C(C)(O)Cc5c(OC)c(O)c6C(=O)C=C(OC)C(=C13)c6c45)C(=C2O)OC KGHNSNSWRMJVND-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 210000002659 acromion Anatomy 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- VANSZAOQCMTTPB-SETSBSEESA-N hypocrellin Chemical compound C1[C@@](C)(O)[C@@H](C(C)=O)C2=C(OC)C(O)=C3C(=O)C=C(OC)C4=C3C2=C2C3=C4C(OC)=CC(=O)C3=C(O)C(OC)=C21 VANSZAOQCMTTPB-SETSBSEESA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 229940109328 photofrin Drugs 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- BQJKVFXDDMQLBE-UHFFFAOYSA-N shiraiachrome A Natural products COC1=C2C3=C(OC)C=C(O)C4=C3C3=C5C(CC(C)(O)C(C(C)=O)C3=C(OC)C4=O)=C(OC)C(=O)C(C(O)=C1)=C25 BQJKVFXDDMQLBE-UHFFFAOYSA-N 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007811 spectroscopic assay Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102432305A CN101502654B (zh) | 2008-12-26 | 2008-12-26 | 高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102432305A CN101502654B (zh) | 2008-12-26 | 2008-12-26 | 高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101502654A CN101502654A (zh) | 2009-08-12 |
CN101502654B true CN101502654B (zh) | 2012-05-30 |
Family
ID=40975117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102432305A Expired - Fee Related CN101502654B (zh) | 2008-12-26 | 2008-12-26 | 高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101502654B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327231A (zh) * | 2011-10-14 | 2012-01-25 | 南京师范大学 | 一种水溶性酞菁二氧化硅纳米粒及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084874A (zh) * | 2007-06-01 | 2007-12-12 | 南京师范大学 | 水溶性竹红菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 |
CN101249075A (zh) * | 2008-03-28 | 2008-08-27 | 南京师范大学 | 基于竹红菌素纳米晶体的水溶性竹红菌素二氧化硅纳米粒的制备方法 |
-
2008
- 2008-12-26 CN CN2008102432305A patent/CN101502654B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101084874A (zh) * | 2007-06-01 | 2007-12-12 | 南京师范大学 | 水溶性竹红菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 |
CN101249075A (zh) * | 2008-03-28 | 2008-08-27 | 南京师范大学 | 基于竹红菌素纳米晶体的水溶性竹红菌素二氧化硅纳米粒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101502654A (zh) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Punjabi et al. | Amplifying the red-emission of upconverting nanoparticles for biocompatible clinically used prodrug-induced photodynamic therapy | |
US8614285B2 (en) | Photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy | |
EP2464384B1 (en) | Salt of a photosensitizing agent for use in photochemical internalization | |
Moret et al. | Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra (hydroxyphenyl)-chlorin (m-THPC) | |
Pramual et al. | Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy | |
Huang et al. | Phthalocyanine-based coordination polymer nanoparticles for enhanced photodynamic therapy | |
CN109395087A (zh) | 一种共递送no供体和纳米药物的纳米共递送系统 | |
CN102961337A (zh) | 靶向复合纳米粒子的制备方法 | |
CN102861334B (zh) | 肿瘤信号响应的主动治疗纳米光动力药物载体及制法 | |
CN104984341B (zh) | 一种近红外激光触发的复合纳米制剂的制备方法 | |
Di Martino et al. | Enhancement of 5-aminolevulinic acid phototoxicity by encapsulation in polysaccharides based nanocomplexes for photodynamic therapy application | |
CN103980434A (zh) | 一种两亲性聚合物、其制备方法、复合纳米药物载体及其制备方法 | |
CN101850118B (zh) | 加载于无机盐载体的脂溶性光敏剂的制备方法及其在制备光动力疗法药物中的应用 | |
Li et al. | Biodegradable materials with disulfide-bridged-framework confine photosensitizers for enhanced photo-immunotherapy | |
CN109464676A (zh) | 一种壳寡糖光敏靶向纳米粒的制备方法及产品 | |
CN101502654B (zh) | 高光稳定性痂囊腔菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 | |
Panagiotakis et al. | Small anticancer drug release by light: Photochemical internalization of porphyrin-β-cyclodextrin nanoparticles | |
CN110115763B (zh) | 一种近红外光激活的多功能脂质体及其制备方法与应用 | |
CN101084874B (zh) | 水溶性竹红菌素二氧化硅纳米粒的制备方法及其在制备静脉注射剂中的应用 | |
US20200140466A1 (en) | Mesoporous organosilica nanoparticles, production method thereof and uses of same | |
CN113827553B (zh) | 用于肿瘤光动力学治疗的瘤内注射给药的酞菁锌在位凝胶及其制备方法 | |
CN105949344B (zh) | 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用 | |
Ouyang et al. | Photothermally driven degradable nanomissile for single-wavelength phototherapy and hypoxia-activated chemotherapy | |
CN102988289A (zh) | 一种脂溶性光敏剂纳米粒的制备方法及其应用 | |
CN102198271B (zh) | 以脂溶性光敏剂为骨架的药物-纳米磷酸钙复合体系的制备方法及其在制备光动力疗法药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGSHU NANJING NORMAL UNIVERSITY DEVELOPMENT INS Free format text: FORMER OWNER: NANJING NORMAL UNIVERSITY Effective date: 20120726 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210046 NANJING, JIANGSU PROVINCE TO: 215500 SUZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120726 Address after: 215500 Changshou City South East Economic Development Zone, Jiangsu, Jin Road, No. 8 Patentee after: Changshu Nanjing Normal University Development Research Institute Co.,Ltd. Address before: Ya Dong New District Yuen Road 210046 in Jiangsu province Nanjing City No. 1 Patentee before: Nanjing Normal University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201224 Address after: Building 3, No.88, Xianshi Road, high tech Zone, Changshu City, Suzhou City, Jiangsu Province Patentee after: Changshu Zijin Intellectual Property Service Co.,Ltd. Address before: 215500 8 Jindu Road, Changshou City Southeast Economic Development Zone, Jiangsu Patentee before: CHANGSHU NANJING NORMAL UNIVERSITY DEVELOPMENT RESEARCH INSTITUTE Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 |
|
CF01 | Termination of patent right due to non-payment of annual fee |